Lymphoma Treatment in India

Lymphoma treatment in India depends on whether the patient has Hodgkin lymphoma or non-Hodgkin lymphoma, the exact subtype, stage, symptoms, molecular characteristics, age and general health.

Lymphoma is not one disease. It is a broad group of cancers that develop in lymphocytes, a type of white blood cell that forms part of the immune system. Doctors need to establish the exact subtype and stage before choosing a protocol. Treatment may involve chemotherapy, immunotherapy, targeted therapy, radiation therapy, antibody-drug conjugates, high-dose chemotherapy, autologous or allogeneic stem cell transplantation, CAR-T cell therapy for selected patients, supportive care or a clinical trial. Some slow-growing lymphomas may initially be managed with active surveillance rather than immediate treatment.

There is no single GAF lymphoma cost sheet. Named partner planning for chemotherapy is $1,500–$8,000+, typically outpatient cycles over 3–6 months. Neighbouring targeted therapy is $8,000–$30,000. Neighbouring immunotherapy is $15,000–$45,000. Neighbouring immune checkpoint inhibitor therapy is $18,000–$50,000. Neighbouring antibody-drug conjugate therapy is $25,000–$70,000. Neighbouring external beam radiotherapy (EBRT) is $1,000–$6,000+ (typically 15–35 sessions over 4–7 weeks). Neighbouring intensity-modulated radiotherapy (IMRT) is $6,500–$14,500. Neighbouring 3D conformal radiotherapy (3D-CRT) is $700–$2,500+. Neighbouring autologous stem cell transplant is $18,000–$48,000 (typically 3–5 weeks). Neighbouring bone marrow transplantation is $25,000–$70,000 (typically 4–8 weeks in or near the unit). Neighbouring allogeneic stem cell transplant is $30,000–$80,000. Neighbouring CAR-T cell therapy is $80,000–$180,000. Neighbouring bone marrow biopsy is $300–$900 (day-care). Comparable US chemotherapy planning is $10,000–$50,000; the BMT sheet is $150,000–$400,000; CAR-T is $400,000–$550,000. These are planning ranges from partner hospital cost sheets, not hospital quotations.

India has specialised haematology-oncology, radiation and transplant centres that manage Hodgkin lymphoma, non-Hodgkin lymphoma, relapsed disease and selected cellular-therapy cases. AIIMS New Delhi describes dedicated haematology services and hematopoietic stem-cell transplantation. That is a published service description, not a GAF ranking. Fortis Gurugram has published a 2026 Centre of Excellence announcement for myeloma and lymphoma combining haematology, diagnostics, transplantation and cellular therapies. That is a hospital announcement, not a catalog ranking.

International patients comparing haematologists commonly start with city lists in Delhi NCR, Mumbai, Bengaluru, Chennai and Hyderabad. Chemotherapy lists sit under medical oncology in Delhi NCR and Mumbai. Radiation lists include Delhi NCR external beam radiotherapy. When a graft is already on the table, bone-marrow-transplantation lists in Delhi NCR, Mumbai, Bengaluru, Chennai and Hyderabad are the live facet. Autologous-transplant lists include Delhi NCR autologous stem cell transplant. CAR-T lists include Delhi NCR CAR-T cell therapy. Partner haematology hospitals in Delhi NCR, Mumbai and Bengaluru, and in Chennai and Hyderabad, are a typical first filter. City cost sheets include Delhi NCR chemotherapy, Delhi NCR bone marrow transplantation and Delhi NCR external beam radiotherapy, with the same live cities for Mumbai, Bengaluru, Chennai and Hyderabad. Kolkata, Vellore, Pune, Ahmedabad and Chandigarh may have haematology or oncology services, but they are not live GAF catalog cities on this site.

Medical note: Lymphoma is not one disease. Hodgkin lymphoma and the many non-Hodgkin subtypes have different biology and therefore require different treatment strategies. Fever during neutropenia, uncontrolled bleeding, sudden breathlessness or new confusion after cellular therapy belongs in a local emergency department, not in a WhatsApp message. A treatment plan should be developed by a haematologist or hemato-oncologist after reviewing biopsy, immunohistochemistry, staging scans and molecular results.

Request a lymphoma records review

Lymphoma Treatment at a Glance

Factor	What patients should know
Disease family	Lymphatic system / lymphocytes, not a single solid tumour
Major categories	Hodgkin lymphoma and non-Hodgkin lymphoma
Named chemotherapy sheet	$1,500–$8,000+; outpatient cycles, 3–6 months typical
Neighbouring immunotherapy	$15,000–$45,000
Neighbouring targeted therapy	$8,000–$30,000
Neighbouring EBRT	$1,000–$6,000+; typically 15–35 sessions over 4–7 weeks
Neighbouring autologous transplant	$18,000–$48,000; typically 3–5 weeks
Neighbouring BMT	$25,000–$70,000; typically 4–8 weeks in or near the unit
Neighbouring CAR-T	$80,000–$180,000; different cellular-therapy product
Specialist	Haematologist / hemato-oncologist, with radiation oncology when a field is planned
Emergency	Neutropenic fever, uncontrolled bleeding, breathlessness or new confusion after cellular therapy belongs in a local emergency department

What Is Lymphoma?

Lymphoma is a cancer of the lymphatic system. The lymphatic system is part of the body's immune system and includes lymph nodes, lymphatic vessels, the spleen, thymus and lymphoid tissues.

Lymphoma develops when abnormal lymphocytes grow or survive in an uncontrolled way. These abnormal cells can accumulate in lymph nodes or other organs and may spread to different parts of the body.

Lymphoma can occur at almost any age. Symptoms depend on the subtype and the areas involved. A painless swelling in the neck, armpit or groin is commonly associated with lymphoma, but swollen lymph nodes are much more frequently caused by infections or other non-cancerous conditions.

Because lymphoma typically forms masses in lymph nodes or other lymphatic tissues rather than circulating as a bone-marrow disease in the way many leukemias do, diagnosis starts with tissue biopsy and staging scans. There can be overlap. Leukemia lists sit on Leukemia Treatment in India.

Ask which lymphoma subtype this is

Hodgkin Lymphoma vs Non-Hodgkin Lymphoma

The two broad categories are Hodgkin lymphoma and non-Hodgkin lymphoma. Hodgkin lymphoma, non-Hodgkin lymphoma, DLBCL, follicular lymphoma, mantle-cell lymphoma and Burkitt lymphoma treatment pages are not live on this site. Use this pillar page plus the named modality sheets.

Hodgkin lymphoma

Hodgkin lymphoma includes classical Hodgkin lymphoma and nodular lymphocyte-predominant Hodgkin lymphoma.

Classical Hodgkin lymphoma is characterised by abnormal Reed-Sternberg cells. It commonly affects lymph nodes and may involve areas such as the chest.

Treatment may involve chemotherapy, radiation therapy and immunotherapy. Stem cell transplantation can be considered in selected patients whose disease has returned or does not respond adequately to initial treatment. Neighbouring immune checkpoint inhibitor therapy is $18,000–$50,000 when a PD-1 drug is the named product.

Non-Hodgkin lymphoma

Non-Hodgkin lymphoma represents a large and diverse group of lymphoid cancers. NHL can be broadly described as B-cell or T-cell, and as indolent (slow-growing) or aggressive (fast-growing).

Examples include diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, mantle cell lymphoma, marginal zone lymphoma, Burkitt lymphoma, peripheral T-cell lymphoma, anaplastic large-cell lymphoma and primary CNS lymphoma.

Because these diseases behave differently, the treatment for one NHL subtype may be completely different from another.

Why Accurate Lymphoma Diagnosis Matters

A lymphoma diagnosis should establish more than the word lymphoma.

Doctors need to determine the exact subtype; whether it is Hodgkin or non-Hodgkin; whether it is B-cell or T-cell; the grade where applicable; the stage; relevant molecular or genetic abnormalities; whether the disease is aggressive or indolent; whether important organs are involved; whether the patient has high-risk features; and whether the disease is newly diagnosed, relapsed or refractory.

This information directly influences treatment. An indolent follicular lymphoma may be observed in selected patients, while an aggressive lymphoma such as DLBCL generally requires systemic therapy.

Symptoms of Lymphoma

Possible symptoms include painless swelling of lymph nodes; a lump in the neck, armpit or groin; persistent or recurrent fever; drenching night sweats; unexplained weight loss; persistent fatigue; loss of appetite; abdominal swelling or discomfort; feeling full after eating a small amount; persistent cough; chest pressure; shortness of breath; frequent infections; and easy bruising or bleeding in some cases.

The classic B symptoms are unexplained fever, drenching night sweats and unintentional weight loss of at least 10% of body weight over six months. These symptoms can be important when doctors assess and stage lymphoma.

Having swollen lymph nodes or night sweats does not automatically mean that a person has lymphoma. Infections are a much more common reason for enlarged lymph nodes. Persistent, unexplained or progressively enlarging lymph nodes should be evaluated by a doctor.

What Causes Lymphoma?

There is usually no single identifiable cause. Lymphoma develops through changes affecting lymphocytes and their growth or survival.

Possible risk factors include increasing age for many lymphoma types, certain viral infections, HIV infection, a weakened immune system, previous organ transplantation, certain autoimmune diseases, some previous cancer treatments, family history in selected cases and certain environmental or occupational exposures.

Having a risk factor does not mean that a person will develop lymphoma. Many people diagnosed with lymphoma do not have an obvious risk factor.

How Is Lymphoma Diagnosed?

A proper lymphoma diagnosis generally involves several stages.

Medical history and examination. The doctor asks about enlarged lymph nodes, fever, night sweats, weight loss, fatigue, infections, previous illnesses, previous cancer treatment, medicines and family history, then examines nodes in the neck, underarms and groin and assesses the liver and spleen.

Blood tests. Investigations may include a complete blood count, peripheral blood examination, kidney and liver function, electrolytes, LDH, uric acid and viral screening where appropriate. Blood tests alone generally cannot establish the exact type of lymphoma.

Lymph node biopsy. Doctors obtain tissue from a lymph node or another suspicious area. Depending on the situation they may perform an excisional biopsy, an incisional biopsy or a core needle biopsy. The specimen may undergo immunohistochemistry, flow cytometry, cytogenetic testing and molecular testing. The goal is to identify the precise subtype.

Immunohistochemistry and flow cytometry. Markers such as CD20, CD3, CD30, CD15, PAX5, ALK, BCL2, BCL6 and MYC may be relevant depending on the suspected disease. The exact panel is selected by the haematopathologist.

PET-CT. PET-CT can identify areas involved by lymphoma, determine disease extent, establish a baseline, assess response and identify residual or recurrent disease. Not every lymphoma behaves the same way on PET imaging.

CT or MRI. CT may assess nodes and organs in the chest, abdomen and pelvis. MRI can be useful when lymphoma involves the brain, spinal cord or other soft tissues.

Bone marrow examination. A marrow biopsy may be recommended in selected patients. Neighbouring bone marrow biopsy is $300–$900 (day-care). Whether it is necessary depends on the subtype, staging approach and other findings.

Molecular and genetic testing. Selected aggressive B-cell lymphomas may require evaluation of MYC, BCL2 and BCL6 abnormalities. Neighbouring precision oncology is $2,000–$7,000 when an NGS panel plus clinic visit is the named product.

Share biopsy and PET-CT reports

Lymphoma Stages

Lymphoma is commonly staged from Stage I to Stage IV.

Stage I. Lymphoma is generally present in a single lymph-node region or a single lymphatic or extranodal site.

Stage II. More than one lymph-node region or certain nearby areas are involved, usually on the same side of the diaphragm.

Stage III. Lymph-node involvement occurs on both sides of the diaphragm and may include the spleen or other sites.

Stage IV. The lymphoma has spread extensively to one or more organs outside the lymphatic system, such as bone marrow or other organs.

Stage IV lymphoma does not automatically mean that treatment is futile. Some advanced lymphomas are highly responsive to treatment. Goals depend heavily on the specific subtype and biology.

Lymphoma Treatment Options in India

Lymphoma treatment is individualised. Depending on the diagnosis, treatment may include one or more of the following.

1. Chemotherapy

Chemotherapy remains important for many lymphoma subtypes. Treatment is generally administered in cycles. The exact combination depends on the subtype.

Examples of commonly used regimens include ABVD-based therapy, A+AVD in selected Hodgkin lymphoma patients, R-CHOP-based therapy, DA-R-EPOCH in selected aggressive lymphomas, bendamustine-based treatment, ICE-based salvage therapy and other subtype-specific regimens. The appropriate regimen should be selected by a haematologist or medical oncologist after the individual diagnosis.

Named chemotherapy is $1,500–$8,000+.

2. Immunotherapy

Depending on the subtype, immunotherapy may include monoclonal antibodies, checkpoint inhibitors and other immune-directed therapies. Rituximab targets CD20 and is an important component of treatment for many CD20-positive B-cell lymphomas. Checkpoint inhibitors such as nivolumab and pembrolizumab have roles in selected Hodgkin lymphoma settings.

Named immunotherapy is $15,000–$45,000. Neighbouring immune checkpoint inhibitor therapy is $18,000–$50,000.

3. Targeted therapy

Targeted therapies interfere with specific molecular pathways. Depending on the subtype, drugs may be directed against CD20, CD30, BTK, BCL2 or other molecular targets. They can be used alone or in combination.

Named targeted therapy is $8,000–$30,000. Neighbouring molecular targeted therapy is $10,000–$32,000.

4. Antibody-drug conjugates

Antibody-drug conjugates combine an antibody with a cancer-killing drug. Examples include therapies targeting CD30 or CD79b in selected subtypes. Neighbouring antibody-drug conjugate therapy is $25,000–$70,000.

5. Radiation therapy

Radiotherapy may be used for selected early-stage lymphomas, localised or bulky disease, after systemic treatment in specific cases, for symptom relief and for certain relapsed lymphomas.

Named external beam radiotherapy (EBRT) is $1,000–$6,000+. Neighbouring IMRT is $6,500–$14,500. Neighbouring 3D-CRT is $700–$2,500+. The named radiation oncologist decides the technique after planning, not from a package list.

6. Stem cell transplantation

Autologous transplant. The patient's own stem cells are collected before high-dose treatment and returned after chemotherapy. This is used in selected lymphoma patients, particularly in certain relapsed or refractory settings. Neighbouring autologous stem cell transplant is $18,000–$48,000.

Allogeneic transplant. Stem cells come from a donor. This can be considered for selected high-risk or relapsed lymphomas. Neighbouring allogeneic stem cell transplant is $30,000–$80,000. Neighbouring haploidentical is $35,000–$85,000.

Named transplant lists sit on Bone Marrow Transplant in India. The BMT sheet is $25,000–$70,000.

7. CAR T-cell therapy

CAR-T collects a patient's T cells, genetically modifies them to recognise cancer cells and returns them to the patient. It is used for selected relapsed or refractory B-cell malignancies. It is not a routine first-line treatment for every lymphoma patient.

Eligibility depends on subtype, previous treatments, response, disease status, overall condition and availability of an appropriate CAR-T programme. Neighbouring CAR-T cell therapy is $80,000–$180,000 (apheresis plus 3–6 weeks nearby). Cellular therapy invoices often have several billed components beyond the infusion itself. It is a different product from BMT.

8. Active surveillance or watchful waiting

Not every lymphoma requires immediate treatment. Some indolent lymphomas may grow slowly and cause few or no symptoms. In selected patients, doctors may recommend regular monitoring — examinations, blood tests, imaging when indicated — and start treatment if the disease becomes clinically significant. Active surveillance is a planned medical strategy, not ignoring the disease.

9. Supportive care

Supportive treatment may include transfusions, antibiotics, antiviral or antifungal treatment, growth-factor support, nausea management, nutrition, tumour-lysis precautions, infection prevention, bleeding management and fertility-preservation discussions where relevant.

Request a named-protocol cost estimate

Lymphoma Treatment by Type

Lymphoma type	Common treatment approaches
Classical Hodgkin lymphoma	Combination chemotherapy, PET-adapted strategies, selected radiation, immunotherapy, transplant for selected relapsed or refractory cases
DLBCL	Immunochemotherapy, often anti-CD20 plus chemotherapy; salvage, transplant, CAR-T or ADC in selected relapsed cases
Follicular lymphoma	Observation when appropriate; anti-CD20 therapy, immunochemotherapy, targeted therapy, selected radiation
Mantle cell lymphoma	Immunochemotherapy, BTK inhibitors, maintenance, transplant in selected patients, cellular therapy in selected relapsed cases
Burkitt lymphoma	Urgent intensive combination chemotherapy, often with CNS-directed therapy
T-cell lymphomas	Subtype-specific chemotherapy, targeted therapy, immunotherapy, radiation, transplant or trials

Treatment should not be selected solely from this table. The precise protocol is determined by a haematologist after reviewing diagnostic, staging and molecular results.

Treatment of Hodgkin Lymphoma in India

Treatment depends on the specific Hodgkin lymphoma subtype, stage and risk features.

For classical Hodgkin lymphoma, treatment may include combination chemotherapy, PET-adapted strategies, radiation therapy in selected cases, immunotherapy, targeted therapy and stem cell transplantation for selected relapsed or refractory cases.

Treatment is often designed to balance disease control with prevention of long-term complications. This is particularly important for younger patients because Hodgkin lymphoma frequently affects adolescents and young adults.

Treatment of Non-Hodgkin Lymphoma in India

Non-Hodgkin lymphoma requires a subtype-specific approach.

Diffuse large B-cell lymphoma. DLBCL is an aggressive B-cell lymphoma. Treatment commonly involves immunochemotherapy, often based on an anti-CD20 antibody combined with chemotherapy. Selected relapsed or refractory patients may be considered for salvage therapy, stem cell transplantation, CAR-T, targeted therapy or antibody-drug conjugates.

Follicular lymphoma. Usually indolent. Some patients do not need immediate treatment. When treatment is necessary, options may include anti-CD20 antibody therapy, immunochemotherapy, targeted therapy and radiation for selected localised disease.

Mantle cell lymphoma. Treatment may involve immunochemotherapy, BTK inhibitors, maintenance therapy, stem cell transplantation in selected patients and cellular therapies in appropriate relapsed cases. Neighbouring maintenance therapy is $4,000–$18,000 when a lower-intensity course after induction is the named product.

Burkitt lymphoma. An aggressive lymphoma that can progress rapidly and requires urgent specialist treatment. Treatment generally involves intensive combination chemotherapy and may include central-nervous-system-directed therapy. Neighbouring intrathecal chemotherapy is $3,000–$10,000 when CNS-directed drug is named separately.

T-cell lymphomas. A diverse group. Options may include combination chemotherapy, targeted therapy, immunotherapy, radiation therapy, stem cell transplantation and clinical trials.

Lymphoma Treatment by Stage

Treatment cannot be selected from stage alone. The subtype must always be considered.

Some early-stage lymphomas can be treated with short-course systemic therapy, radiation therapy, combined-modality treatment or, in highly selected circumstances, a procedure for a localised problem.

Advanced lymphoma may require combination chemotherapy, immunotherapy, targeted therapy, maintenance therapy, stem cell transplantation or CAR-T in selected relapsed cases. Some advanced lymphomas remain highly treatable. A higher stage does not automatically mean there are no effective options.

Treatment for Relapsed or Refractory Lymphoma

Lymphoma is called relapsed when it returns after a period of response. It is called refractory when it does not respond adequately or progresses despite therapy.

Management may include second-line chemotherapy, immunotherapy, targeted therapy, antibody-drug conjugates, radiation therapy, autologous or allogeneic transplant, CAR-T, bispecific antibodies and clinical trials. The appropriate approach depends on the exact subtype and the treatments already received.

Request a relapsed-lymphoma review

Lymphoma Treatment for Children

Childhood lymphoma requires treatment by a paediatric oncology or paediatric haematology team. Childhood lymphoma differs biologically and clinically from many adult lymphomas.

Treatment can include chemotherapy, targeted therapy, immunotherapy, radiation in selected situations, stem cell transplantation, CNS-directed therapy and clinical trials. Protocols pay particular attention to long-term effects because children may live for decades after successful treatment.

Families travelling to India should look for a dedicated paediatric hemato-oncology and paediatric BMT programme. Neighbouring pediatric bone marrow transplantation is $28,000–$75,000. Adult floors are not a substitute because a brochure says they treat all ages.

Paediatric doctor lists include Delhi NCR paediatric haematology and Chennai paediatric haematology.

Share a child's reports for a paediatric lymphoma opinion

Lymphoma Treatment for Adults

Adult lymphoma treatment depends on age, functional status, other medical conditions, subtype, stage, molecular features, disease burden, treatment response, previous treatment and transplant or CAR-T eligibility.

Older adults can benefit from a personalised plan rather than an automatic assumption that intensive treatment is unsuitable.

Lymphoma Treatment During Pregnancy

A lymphoma diagnosis during pregnancy requires specialised multidisciplinary care. The plan must consider subtype, aggressiveness, stage, gestational age, maternal health, fetal health and timing of delivery. Treatment should never be delayed or changed without specialist assessment.

Lymphoma Treatment Cost in India

There is no single lymphoma treatment cost in India because lymphoma is a group of diseases. Treatment may range from a limited course of chemotherapy or radiotherapy to prolonged targeted therapy, transplantation or cellular therapy.

A patient with indolent follicular lymphoma who is observed has a different pathway from a patient with DLBCL who needs immunochemotherapy, PET-CT restaging and possibly an autologous transplant. A relapsed B-cell lymphoma that proceeds to CAR-T is a different product again.

International patients should ask hospitals to provide a written estimate separating initial evaluation, pathology review, PET-CT, treatment drugs, hospitalisation, radiation planning and fractions, supportive care, ICU, stem cell collection and transplant, CAR-T components, follow-up and what is excluded if complications occur.

WhatsApp +91 90443 46292 for an itemised lymphoma estimate

What Is Included in a Lymphoma Treatment Estimate?

Ask whether the quotation includes doctor consultation, pathology review, immunohistochemistry, molecular testing, PET-CT, CT or MRI, chemotherapy medicines, immunotherapy, targeted medicines, day-care charges, hospital admission, doctor and nursing fees, radiation planning and sessions, blood products, antibiotics and supportive medicines, ICU if required, stem-cell collection and processing, transplant admission, CAR-T collection and manufacturing fees, and follow-up investigations.

A low initial quotation can become substantially higher if expensive medicines, prolonged admission or complications are excluded. Request an itemised estimate before travelling.

How to Choose a Lymphoma Centre in India

There is no single hospital that is best for every lymphoma patient.

Look for a dedicated haematology or hemato-oncology team that already treats the relevant subtype, access to haematopathology and molecular diagnostics, PET-CT, radiation oncology when a field may be needed, a blood bank, infection-control and ICU support, and — if a graft or CAR-T may be needed — a unit that already performs that work.

Live GAF city lists currently cover Delhi NCR, Mumbai, Bengaluru, Chennai and Hyderabad. Kolkata, Vellore, Pune, Ahmedabad, Kochi, Jaipur, Chandigarh and Lucknow are not live GAF catalog cities on this site.

Catalog haematologists currently tagged to blood-cancer or transplant lists include Dr. Ajay Gupta and Dr. Akash Khandelwal in Delhi NCR; Dr. Akshay Shah and Dr. Muralidaran C in Mumbai; Dr. Govind Eriat and Dr. Neema Bhat in Bengaluru; Dr. M. Gopinathan and Dr. Prabu P in Chennai; and Dr. K. Karuna Kumar and Dr. Narender Kumar Thota in Hyderabad. Neighbouring paediatric lists include Dr. Amita Mahajan in Delhi NCR, Dr. Vipin Khandelwal in Mumbai, Dr. Prerana Nesargi in Bengaluru, Dr. G. Vimal Kumar in Chennai and Dr. Parinitha Reddy Gutha in Hyderabad. A catalog tag is not a volume, outcome or ranking claim.

Catalog hospitals currently affiliated with those tagged lists include Indraprastha Apollo Hospital, BLK-Max Super Speciality Hospital and Medanta - The Medicity in Delhi NCR; Wockhardt Hospital, Mumbai and Gleneagles Hospital, Mumbai; Apollo Hospitals, Bannerghatta Road and Gleneagles Hospitals, Bengaluru; Apollo Hospital, Chennai and MGM Healthcare, Chennai; and Yashoda Hospitals, Secunderabad and KIMS Hospitals, Secunderabad.

Find a lymphoma specialist in India

WhatsApp +91 90443 46292 to match a haematologist

• Haematology hospitals in Delhi NCR
• Haematology hospitals in Mumbai
• Haematology hospitals in Bengaluru
• Haematology hospitals in Chennai
• Haematology hospitals in Hyderabad

Why International Patients Choose India for Lymphoma Treatment

For patients travelling from Africa, the Middle East, Central Asia and other regions, lymphoma treatment in India may offer access to multidisciplinary haematology, radiation and transplant services within large tertiary-care hospitals.

Medical treatment is only one part of the journey. The provider should ideally also coordinate remote record review, a preliminary haematologist opinion, a treatment plan, admission planning, visa-support documentation where applicable, airport assistance, accommodation, interpreter support, local transportation, financial estimates and post-treatment follow-up.

For aggressive lymphoma, unnecessary travel delays can be clinically important. Obtain advice from a qualified haematologist about the urgency of travel before making arrangements.

Lymphoma Treatment Process in India for International Patients

Step 1: Send medical records

The initial file may include biopsy and histopathology reports, immunohistochemistry, PET-CT, CT or MRI, blood reports, bone marrow reports, molecular results, previous chemotherapy or radiotherapy records, discharge summaries and current medicines.

Step 2: Haematologist review

A specialist reviews the available records and determines the likely subtype, additional tests required, treatment urgency, potential options and whether transplant or CAR-T assessment may be needed.

Step 3: Treatment plan and estimate

The hospital can then provide an individualised plan and estimated cost from named modality sheets. Ask which investigations need to be repeated after arrival.

Step 4: Travel and admission

Once medically appropriate, the international-patient team can coordinate admission.

Step 5: Treatment

Treatment may involve outpatient care, day-care treatment, a radiation course, prolonged hospitalisation or a combination of these.

Step 6: Response assessment

The team evaluates response through examination, blood tests, PET-CT or other imaging, and marrow or molecular tests as appropriate.

Step 7: Long-term follow-up

Follow-up may involve clinic review, blood tests, imaging, medication monitoring, infection surveillance, late-effect monitoring and transplant or CAR-T follow-up.

Plan a lymphoma treatment journey

What Medical Records Should You Send?

Essential reports include the biopsy report, histopathology, immunohistochemistry, PET-CT or CT/MRI, complete blood count, kidney and liver function, LDH, bone marrow report if performed, molecular or genetic results, previous chemotherapy and radiotherapy records, discharge summaries, current medicines and the doctor's clinical notes.

The biopsy and immunohistochemistry reports are particularly important because lymphoma treatment depends heavily on the exact subtype.

Questions to Ask a Lymphoma Specialist in India

1. What exact type of lymphoma do I have?
2. Is it Hodgkin or non-Hodgkin lymphoma?
3. What is the subtype?
4. What stage is the disease?
5. Is the lymphoma aggressive or indolent?
6. Are additional pathology tests required?
7. Do I need PET-CT?
8. Do I need molecular or genetic testing?
9. What treatment do you recommend?
10. How many cycles will I need?
11. Will I need radiation therapy?
12. Is immunotherapy or targeted therapy appropriate?
13. Is stem cell transplantation likely to be needed?
14. Could CAR T-cell therapy become relevant?
15. What are the major side effects?
16. How will treatment response be assessed?
17. How long will treatment take?
18. What is the estimated treatment cost from named sheets?
19. Which parts of the estimate are not included?
20. Will I need hospitalisation?
21. Can I continue normal work during treatment?
22. What warning signs require emergency care?
23. Are clinical trials available?
24. What follow-up will I need after treatment?

When Should You Seek a Second Opinion?

A second opinion can be particularly useful when the subtype is unusual, the pathology is uncertain, the disease is relapsed or refractory, stem cell transplantation or CAR-T is being considered, several approaches are possible, the proposed treatment is intensive, or the family wants confirmation before starting. For rare or complex lymphomas, pathology review by an experienced haematopathologist can be especially valuable.

How Long Does Lymphoma Treatment Take?

There is no single duration. It may range from several weeks to many months depending on the diagnosis and strategy.

Some chemotherapy regimens are delivered every few weeks for several cycles. Radiotherapy may take several weeks. Stem cell transplantation requires evaluation, conditioning, transplantation and recovery. CAR-T requires evaluation, cell collection, manufacturing, preparative treatment, infusion and close monitoring. Indolent lymphoma and maintenance can continue for years.

Side Effects of Lymphoma Treatment

Side effects vary according to the treatment.

Chemotherapy may cause fatigue, nausea, vomiting, hair loss, reduced blood counts, infection risk, mouth ulcers, appetite changes, constipation or diarrhoea, and peripheral neuropathy with certain medicines.

Immunotherapy may cause fever, fatigue, infusion reactions, skin changes and, in some patients, inflammation involving organs.

Radiation effects depend on the body region and may include fatigue, skin changes, local inflammation, nausea and changes related to the treated organ.

Transplantation can cause severe low blood counts, infection risk, mucositis, fatigue, organ complications and graft-versus-host disease after allogeneic transplantation.

CAR-T can cause cytokine release syndrome, neurological toxicity, low blood counts, infections and other immune-related complications. Cellular therapy should be performed at appropriately equipped centres.

Lymphoma Treatment and Fertility

Some lymphoma treatments can affect fertility. This is particularly important for children, adolescents and younger adults, including many patients with Hodgkin lymphoma. Where clinically safe and practical, discuss fertility preservation before starting treatment.

Nutrition During Lymphoma Treatment

There is no special diet proven to eliminate lymphoma. Priorities generally include adequate calories and protein, safe food handling, hydration and management of nausea or weight loss. Be cautious about herbal products or supplements that can interact with cancer medicines.

Lymphoma and Infection Risk

Lymphoma itself and intensive chemotherapy can reduce normal immune defences. During periods of severe neutropenia, fever can require urgent medical assessment.

A lymphoma patient receiving intensive treatment who develops fever should contact the treating medical team immediately. If fever, uncontrolled bleeding, sudden confusion or breathlessness develops away from the unit, go to a local emergency department. Do not wait for a WhatsApp reply.

Can Lymphoma Be Cured?

The answer depends on the exact lymphoma. Some lymphomas can be cured, while others can often be controlled for long periods.

Hodgkin lymphoma is generally considered a highly treatable cancer, and many patients achieve long-term remission. Several aggressive non-Hodgkin lymphomas can also be cured with appropriate treatment. Some indolent lymphomas behave more like chronic diseases and may require treatment at different points over many years.

A doctor should discuss prognosis using the exact subtype, stage, molecular features, age, overall health, response to treatment and disease status. A diagnosis of lymphoma should not automatically be interpreted as an incurable disease.

Lymphoma Survival Rate

Survival statistics are population-level measurements and should not be used to predict the outcome of an individual patient. Survival differs significantly between subtypes and is affected by age, stage, molecular characteristics, general health, response to treatment and whether the disease is newly diagnosed or relapsed.

For an individual patient, the treating haematologist is best placed to explain prognosis after reviewing the complete pathology and staging information.

Frequently Asked Questions About Lymphoma Treatment in India

What is the best treatment for lymphoma?

There is no single treatment that is best for every lymphoma patient. Treatment depends on the exact subtype, stage, molecular characteristics, previous treatment and overall health.

Is lymphoma treatment available in India?

Yes. Major Indian tertiary hospitals provide haematology, medical oncology, radiation oncology, pathology, stem cell transplantation and, at selected centres, cellular therapies.

Is lymphoma a blood cancer?

Yes. Lymphoma is generally classified as a blood or hematologic cancer because it arises from lymphocytes.

Is lymphoma curable?

Some types can be cured, while others can be controlled for long periods. Prognosis depends heavily on the specific lymphoma.

What is the cost of lymphoma treatment in India?

There is no single package. Named chemotherapy is $1,500–$8,000+. Neighbouring EBRT is $1,000–$6,000+. Neighbouring autologous transplant is $18,000–$48,000. Neighbouring BMT is $25,000–$70,000. Neighbouring CAR-T is $80,000–$180,000. A patient-specific quotation is more meaningful than a generic lymphoma cost figure.

Does every lymphoma patient need chemotherapy?

No. Some indolent lymphomas can be monitored initially, while others require systemic treatment. The decision depends on the subtype and clinical situation.

Does lymphoma require surgery?

Surgery is usually not the main treatment. Biopsy is important for diagnosis. Radiation and systemic treatments are used more commonly for treatment.

Does every lymphoma patient need a bone marrow transplant?

No. Many patients are managed without transplantation. Transplant is considered for selected patients based on subtype, relapse risk, treatment response, age, health and donor availability. Transplant lists sit on Bone Marrow Transplant in India.

Is Stage 4 lymphoma curable?

Some Stage 4 lymphomas are highly treatable and can achieve long-term remission or cure. Stage alone does not determine the outcome.

Can lymphoma come back after treatment?

Yes. If lymphoma returns, additional options may include chemotherapy, targeted therapy, immunotherapy, transplantation, CAR-T or clinical trials depending on the subtype.

What is the difference between lymphoma and leukemia?

Leukemia primarily involves abnormal blood and bone marrow cells, while lymphoma typically forms masses in lymph nodes or other lymphatic tissues. There can be overlap. Leukemia lists sit on Leukemia Treatment in India.

Can lymphoma be treated successfully in children?

Many childhood lymphomas are highly treatable, but the outcome depends on the exact subtype, risk group, treatment response and other factors. Children should ideally be treated at specialised paediatric hemato-oncology centres.

Does CAR-T use the lymphoma chemotherapy sheet?

No. Neighbouring CAR-T cell therapy is $80,000–$180,000 and is a different cellular-therapy product.

Which city in India is best for lymphoma treatment?

There is no single best city. Delhi NCR, Mumbai, Bengaluru, Chennai and Hyderabad are live GAF catalog cities. Choose a named haematology unit that already treats the relevant subtype.

Can international patients get lymphoma treatment in India?

Yes. Medical records can usually be reviewed before travel to help determine the appropriate specialist, hospital and treatment pathway.

Is a second opinion useful for lymphoma?

A second opinion can be particularly useful when the diagnosis is complex, transplantation or CAR-T is being considered, or the disease has relapsed. The second specialist should review the original pathology, immunohistochemistry and staging scans.

Key Takeaways

• Lymphoma is a broad group of cancers, not a single disease. The two major categories are Hodgkin lymphoma and non-Hodgkin lymphoma.
• Accurate biopsy and subtyping are critical before treatment.
• Treatment may include chemotherapy, immunotherapy, targeted therapy, radiotherapy, transplantation or CAR-T.
• Some slow-growing lymphomas can initially be monitored. Aggressive lymphomas generally need prompt systemic treatment.
• Advanced-stage lymphoma can still be highly treatable depending on the subtype.
• There is no single GAF lymphoma package. Named chemotherapy is $1,500–$8,000+. Neighbouring EBRT is $1,000–$6,000+. Neighbouring autologous transplant is $18,000–$48,000. Neighbouring BMT is $25,000–$70,000. Neighbouring CAR-T is $80,000–$180,000.
• Transplant lists sit on Bone Marrow Transplant in India. Leukemia lists sit on Leukemia Treatment in India.
• Fever during neutropenia, uncontrolled bleeding, sudden confusion or breathlessness belongs in a local emergency department.

Share biopsy, immunohistochemistry, PET-CT or CT reports, blood tests, bone marrow report if performed and previous treatment records before making travel arrangements.

Request a lymphoma treatment plan

Share records for a lymphoma review

Message a coordinator on WhatsApp

Request a cost review on WhatsApp

Why GAF Healthcare Can Help International Patients

For an international patient, arranging lymphoma treatment involves medical-record collection, specialist review, hospital coordination, treatment estimates, appointment scheduling, travel planning, local assistance and follow-up coordination.

GAF Healthcare can help coordinate the process with appropriate hospitals and haematology teams. A medical opinion should always come from the treating haematologist or hemato-oncologist. GAF Healthcare's role is to facilitate access and coordination rather than replace the medical team.

Related Treatment and Cost Guides

• Leukemia Treatment in India — named chemotherapy $1,500–$8,000+
• Bone Marrow Transplant in India — named BMT sheet $25,000–$70,000
• Chemotherapy — $1,500–$8,000+
• Immunotherapy — $15,000–$45,000
• Targeted therapy — $8,000–$30,000
• External beam radiotherapy (EBRT) — $1,000–$6,000+
• Autologous stem cell transplant — $18,000–$48,000
• CAR-T cell therapy — $80,000–$180,000
• Allogeneic stem cell transplant — $30,000–$80,000
• Pediatric bone marrow transplantation — $28,000–$75,000
• Bone marrow biopsy — $300–$900

Hodgkin lymphoma, non-Hodgkin lymphoma, DLBCL, follicular lymphoma, mantle-cell lymphoma, Burkitt lymphoma and blood-cancer treatment pages are not live on this site. Use the named modality sheets rather than an invented disease page. Thalassemia lists sit on Thalassemia Treatment in India. Sickle cell lists sit on Sickle Cell Anemia Treatment in India. Myeloma lists sit on Multiple Myeloma Treatment in India. Aplastic anemia lists sit on Aplastic Anemia Treatment in India. Autologous transplant lists sit on Autologous Bone Marrow Transplant in India. Fanconi anemia lists sit on Fanconi Anemia Treatment in India.

Chemotherapy, radiation, transplant and CAR-T lists treat different briefs. They are not a substitute lymphoma package.

Top 10 Medical Sources

1. National Cancer Institute — Hodgkin lymphoma treatment — chemotherapy, radiation, immunotherapy and transplant approaches.
2. National Cancer Institute — Non-Hodgkin lymphoma treatment — subtype-specific NHL management.
3. National Cancer Institute — Lymphoma information — overview of lymphoma types.
4. American Cancer Society — Hodgkin lymphoma — diagnosis and treatment overview.
5. American Cancer Society — Non-Hodgkin lymphoma — NHL subtypes and treatment families.
6. NHS — Lymphoma — symptoms, diagnosis and treatment overview.
7. World Health Organization — Cancer — global cancer context.
8. GAF Healthcare chemotherapy — partner USD planning of $1,500–$8,000+.
9. GAF Healthcare bone marrow transplantation — partner USD planning of $25,000–$70,000.
10. GAF Healthcare CAR-T cell therapy — partner USD planning of $80,000–$180,000.

Last reviewed against the cited sources: October 2026.

Medical Disclaimer

This page is intended for general educational purposes and should not replace an examination, pathology review, diagnosis or individualized medical advice from a qualified haematologist or oncologist.

Lymphoma treatment is individualized. Suitability, protocol, risks, recovery and expected results vary from patient to patient. Treatment protocols and drug availability can change as evidence and regulatory approvals evolve.

If you develop fever during neutropenia, uncontrolled bleeding, sudden confusion or breathlessness, seek urgent medical attention in a local emergency department.